Κάνναβη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Κάνναβη" in Greek language version.

refsWebsite
Global rank Greek rank
4th place
4th place
1st place
1st place
2nd place
3rd place
6th place
5th place
3rd place
6th place
low place
low place
219th place
194th place
607th place
556th place
274th place
297th place
731st place
623rd place
2,650th place
3,291st place
2,494th place
1,684th place
360th place
483rd place
287th place
172nd place
8,677th place
low place
1,020th place
3,782nd place
175th place
218th place
low place
low place
1,933rd place
2,925th place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
218th place
156th place
5th place
8th place
1,544th place
1,892nd place
1,989th place
939th place
3,401st place
12th place
low place
3,288th place
low place
low place
low place
low place
low place
low place

algemeiner.com

archive.org

ars-grin.gov

books.google.com

cdc.gov

dailymail.co.uk

doi.org

dx.doi.org

druglibrary.org

eiek.gr

etymonline.com

ggb.gr

in.gr

jamanetwork.com

archpsyc.jamanetwork.com

jewishjournal.com

kethea-strofi.gr

medicalmarijuanainformation.com

ministryofjustice.gr

nel.edu

nhs.uk

nih.gov

ncbi.nlm.nih.gov

  • El-Alfy, Abir T (Jun 2010). «Antidepressant-like effect of delta-9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L». Pharmacology Biochemistry and Behavior 95 (4): 434–42. doi:10.1016/j.pbb.2010.03.004. PMID 20332000. 
  • Fusar-Poli P, Crippa JA, Bhattacharyya S (January 2009). «Distinct effects of delta-9-tetrahydrocannabinol and Cannabidiol on Neural Activation during Emotional Processing». Archives of General Psychiatry 66 (1): 95–105. doi:10.1001/archgenpsychiatry.2008.519. PMID 19124693. http://archpsyc.jamanetwork.com/article.aspx?articleid=482939.  Σφάλμα αναφοράς: Μη έγκυρη ετικέτα <ref> • όνομα " pmid19124693 " ορίζεται πολλές φορές με διαφορετικό περιεχόμενο
  • Ben Amar M (2006). «Cannabinoids in medicine: a review of their therapeutic potential». Journal of Ethnopharmacology 105 (1–2): 1–25. doi:10.1016/j.jep.2006.02.001. PMID 16540272. 
  • Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND (2005). "Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors". Behavioural Brain Research 164 (2): 206–13. doi:10.1016/j.bbr.2005.06.021. PMID 16140402.
  • Carter GT, Rosen BS (2001). "Marijuana in the management of amyotrophic lateral sclerosis". The American Journal of Hospice & Palliative Care 18 (4): 264–70. doi:10.1177/104990910101800411. PMID 11467101.
  • Weydt P, Hong S, Witting A, Möller T, Stella N, Kliot M (2005). "Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival". Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 6 (3): 182–4. doi:10.1080/14660820510030149. PMID 16183560.
  • Ganon-Elazar E, Akirav I (2009). "Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance". J. Neurosci 29 (36): 11078–88. doi:10.1523/JNEUROSCI.1223-09.2009. PMID 19741114. Lay summary – PsychCentral (5 November 2009).
  • Patsos HA; Hicks DJ; Dobson RR; Greenhough, A; Woodman, N; Lane, JD; Williams, AC; Paraskeva, C (2005). "The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2". Gut 54 (12): 1741–50. doi:10.1136/gut.2005.073403. PMC 1774787. PMID 16099783.
  • Fox SH, Kellett M, Moore AP, Crossman AR, Brotchie JM (2002). "Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia". Movement Disorders 17 (1): 145–9. doi:10.1002/mds.1280. PMID 11835452.
  • Di Carlo G, Izzo AA (2003). "Cannabinoids for gastrointestinal diseases: potential therapeutic applications". Expert Opinion on Investigational Drugs 12 (1): 39–49. doi:10.1517/13543784.12.1.39. PMID 12517253.
  • Lorente M; Carracedo A; Torres S; Natali, Francesco; Egia, Ainara; Hernández-Tiedra, Sonia; Salazar, María; Blázquez, Cristina et al. (2009). "Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis". Glia 57 (13): 1374–85. doi:10.1002/glia.20856. PMID 19229996.
  • Sylvestre DL, Clements BJ, Malibu Y (2006). "Cannabis use improves retention and virological outcomes in patients treated for hepatitis C". European Journal of Gastroenterology & Hepatology 18 (10): 1057–63. doi:10.1097/01.meg.0000216934.22114.51. PMID 16957511.
  • Powles T; te Poele R; Shamash J; Chaplin, T; Propper, D; Joel, S; Oliver, T; Liu, WM (2005). "Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway". Blood 105 (3): 1214–21. doi:10.1182/blood-2004-03-1182. PMID 15454482
  • Casanova ML; Blázquez C; Martínez-Palacio J; Villanueva, Concepción; Fernández-Aceñero, M. Jesús; Huffman, John W.; Jorcano, José L.; Guzmán, Manuel (2003). "Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors". The Journal of Clinical Investigation 111 (1): 43–50. doi:10.1172/JCI16116. PMC 151833. PMID 12511587.
  • Kreitzer AC, Malenka RC (2005). "Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models". Nature 445 (7128): 643–7. doi:10.1038/nature05506. PMID 17287809. Lay summary – Stanford University School of Medicine (7 February 2007).
  • ^ Wilkinson, J. D.; Williamson, E. M. (2007). "Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis". Journal of Dermatological Science 45 (2): 87–92. doi:10.1016/j.jdermsci.2006.10.009. PMID 17157480.
  • Howard, J.; Anie, K. A.; Holdcroft, A.; Korn, S.; Davies, S. C. (2005). "Cannabis use in sickle cell disease: A questionnaire study". British Journal of Haematology 131 (1): 123–128. doi:10.1111/j.1365-2141.2005.05723.x. PMID 16173972
  • Singer HS (2005). "Tourette's syndrome: from behaviour to biology". Lancet Neurol 4 (3): 149–59. doi:10.1016/S1474-4422(05)01012-4. PMID 15721825.
  • Sandyk R, Awerbuch G (1988). "Marijuana and Tourette's syndrome". Journal of Clinical Psychopharmacology 8 (6): 444–5. doi:10.1097/00004714-198812000-00021. PMID 3235704.
  • Müller-Vahl KR, Kolbe H, Dengler R (1997). "Gilles de la Tourette syndrome. Effect of nicotine, alcohol and marihuana on clinical symptoms". Der Nervenarzt 68 (12): 985–9. PMID 9465342.
  • Lange, Peter (2007-12). «Cannabis and the lung». Thorax 62 (12): 1036–1037. doi:10.1136/thx.2007.084830. ISSN 0040-6376. PMID 18025140. PMC 2094280. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2094280/. 
  • Tashkin, DP (June 2013). «Effects of marijuana smoking on the lung.». Annals of the American Thoracic Society 10 (3): 239–47. doi:10.1513/annalsats.201212-127fr. PMID 23802821. 
  • «Adverse health effects of non-medical cannabis use». Lancet 374 (9698): 1383–91. 2009. doi:10.1016/S0140-6736(09)61037-0. PMID 19837255. 
  • Batalla, Albert et. al (2013). «Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings». PLoS ONE 8 (2): e55821. doi:10.1371/journal.pone.0055821. PMID 23390554. 
  • Kedzior, Karina; Laeber, Lisa. «A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- a meta-analysis of 31 studies». BMC Psychiatry 14 (1): 136. doi:10.1186/1471-244X-14-136. PMID 24884989. 

pubmedcentral.nih.gov

oed.com

dictionary.oed.com

procon.org

medicalmarijuana.procon.org

psychologytoday.com

rehab.ch

sagepub.com

tde.sagepub.com

scholaruniverse.com

springer.com

link.springer.com

ucsd.edu

cmcr.ucsd.edu

ukcia.org

unodc.org

vice.com

web.archive.org

worldcat.org